mklives

SUNPHARMA.. bullish?

Long
mklives Updated   
NSE:SUNPHARMA   SUN PHARMACEUTICAL
SUNPHARMA after a long time, is crossing 200 dma
news about the whistle blower went in favour of the company
can be a contrarion bet in a weak market
above 441 close, can give 10 % returns possibly.
Comment:
sun pharma breaks above 200 dma which is good.. rsi above 60.
buy on dips to 441 and targets of 485 as first target. weekly rsi has double bottomed. looks like 500 can be tested but is a strong resistance since it is 100 weekly dma

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.